132 related articles for article (PubMed ID: 28674882)
1. Identification of Core-Fucosylated Glycoproteome in Human Plasma.
Cao Q; Zhao Q; Qian X; Ying W
Methods Mol Biol; 2017; 1619():127-137. PubMed ID: 28674882
[TBL] [Abstract][Full Text] [Related]
2. Strategy integrating stepped fragmentation and glycan diagnostic ion-based spectrum refinement for the identification of core fucosylated glycoproteome using mass spectrometry.
Cao Q; Zhao X; Zhao Q; Lv X; Ma C; Li X; Zhao Y; Peng B; Ying W; Qian X
Anal Chem; 2014 Jul; 86(14):6804-11. PubMed ID: 24914453
[TBL] [Abstract][Full Text] [Related]
3. A precise approach in large scale core-fucosylated glycoprotein identification with low- and high-normalized collision energy.
Ma C; Zhang Q; Qu J; Zhao X; Li X; Liu Y; Wang PG
J Proteomics; 2015 Jan; 114():61-70. PubMed ID: 25220145
[TBL] [Abstract][Full Text] [Related]
4. Identification of Core-Fucosylated Glycoproteins by Single-Step Truncation of N-Glycans.
Min Y; Zhao X; Ying W
Curr Protoc; 2024 Jan; 4(1):e982. PubMed ID: 38270535
[TBL] [Abstract][Full Text] [Related]
5. Improvement of core-fucosylated glycoproteome coverage via alternating HCD and ETD fragmentation.
Ma C; Qu J; Li X; Zhao X; Li L; Xiao C; Edmunds G; Gashash E; Song J; Wang PG
J Proteomics; 2016 Sep; 146():90-8. PubMed ID: 27282921
[TBL] [Abstract][Full Text] [Related]
6. Elucidation of N-glycosites within human plasma glycoproteins for cancer biomarker discovery.
Drake P; Schilling B; Gibson B; Fisher S
Methods Mol Biol; 2013; 951():307-22. PubMed ID: 23296540
[TBL] [Abstract][Full Text] [Related]
7. Analysis of fucosylation in liver-secreted N-glycoproteins from human hepatocellular carcinoma plasma using liquid chromatography with tandem mass spectrometry.
Ji ES; Hwang H; Park GW; Lee JY; Lee HK; Choi NY; Jeong HK; Kim KH; Kim JY; Lee S; Ahn YH; Yoo JS
Anal Bioanal Chem; 2016 Nov; 408(27):7761-7774. PubMed ID: 27565792
[TBL] [Abstract][Full Text] [Related]
8. Glycoproteins Enrichment and LC-MS/MS Glycoproteomics in Central Nervous System Applications.
Zhu R; Song E; Hussein A; Kobeissy FH; Mechref Y
Methods Mol Biol; 2017; 1598():213-227. PubMed ID: 28508363
[TBL] [Abstract][Full Text] [Related]
9. Large-scale identification of core-fucosylated glycopeptide sites in pancreatic cancer serum using mass spectrometry.
Tan Z; Yin H; Nie S; Lin Z; Zhu J; Ruffin MT; Anderson MA; Simeone DM; Lubman DM
J Proteome Res; 2015 Apr; 14(4):1968-78. PubMed ID: 25732060
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of core fucosylation of serum proteins in liver diseases by LC-MS-MRM.
Ma J; Sanda M; Wei R; Zhang L; Goldman R
J Proteomics; 2018 Oct; 189():67-74. PubMed ID: 29427759
[TBL] [Abstract][Full Text] [Related]
11. Glycoproteomic Alterations in Drug-Resistant Nonsmall Cell Lung Cancer Cells Revealed by Lectin Magnetic Nanoprobe-Based Mass Spectrometry.
Waniwan JT; Chen YJ; Capangpangan R; Weng SH; Chen YJ
J Proteome Res; 2018 Nov; 17(11):3761-3773. PubMed ID: 30261726
[TBL] [Abstract][Full Text] [Related]
12. Maximizing Glycoproteomics Results through an Integrated Parallel Accumulation Serial Fragmentation Workflow.
Baerenfaenger M; Post MA; Zijlstra F; van Gool AJ; Lefeber DJ; Wessels HJCT
Anal Chem; 2024 Jun; 96(22):8956-8964. PubMed ID: 38776126
[TBL] [Abstract][Full Text] [Related]
13. pGlyco 2.0 enables precision N-glycoproteomics with comprehensive quality control and one-step mass spectrometry for intact glycopeptide identification.
Liu MQ; Zeng WF; Fang P; Cao WQ; Liu C; Yan GQ; Zhang Y; Peng C; Wu JQ; Zhang XJ; Tu HJ; Chi H; Sun RX; Cao Y; Dong MQ; Jiang BY; Huang JM; Shen HL; Wong CCL; He SM; Yang PY
Nat Commun; 2017 Sep; 8(1):438. PubMed ID: 28874712
[TBL] [Abstract][Full Text] [Related]
14. Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.
Liu T; Qian WJ; Gritsenko MA; Camp DG; Monroe ME; Moore RJ; Smith RD
J Proteome Res; 2005; 4(6):2070-80. PubMed ID: 16335952
[TBL] [Abstract][Full Text] [Related]
15. Integrated GlycoProteome Analyzer (I-GPA) for Automated Identification and Quantitation of Site-Specific N-Glycosylation.
Park GW; Kim JY; Hwang H; Lee JY; Ahn YH; Lee HK; Ji ES; Kim KH; Jeong HK; Yun KN; Kim YS; Ko JH; An HJ; Kim JH; Paik YK; Yoo JS
Sci Rep; 2016 Feb; 6():21175. PubMed ID: 26883985
[TBL] [Abstract][Full Text] [Related]
16. A strategy for precise and large scale identification of core fucosylated glycoproteins.
Jia W; Lu Z; Fu Y; Wang HP; Wang LH; Chi H; Yuan ZF; Zheng ZB; Song LN; Han HH; Liang YM; Wang JL; Cai Y; Zhang YK; Deng YL; Ying WT; He SM; Qian XH
Mol Cell Proteomics; 2009 May; 8(5):913-23. PubMed ID: 19139490
[TBL] [Abstract][Full Text] [Related]
17. Liquid chromatography-tandem mass spectrometry-based fragmentation analysis of glycopeptides.
Nilsson J
Glycoconj J; 2016 Jun; 33(3):261-72. PubMed ID: 26780731
[TBL] [Abstract][Full Text] [Related]
18. A multi-parallel N-glycopeptide enrichment strategy for high-throughput and in-depth mapping of the N-glycoproteome in metastatic human hepatocellular carcinoma cell lines.
Jiang B; Huang J; Yu Z; Wu M; Liu M; Yao J; Zhao H; Yan G; Ying W; Cao W; Yang P
Talanta; 2019 Jul; 199():254-261. PubMed ID: 30952254
[TBL] [Abstract][Full Text] [Related]
19. Improving Blood Plasma Glycoproteome Coverage by Coupling Ultracentrifugation Fractionation to Electrostatic Repulsion-Hydrophilic Interaction Chromatography Enrichment.
Adav SS; Hwa HH; de Kleijn D; Sze SK
J Proteome Res; 2015 Jul; 14(7):2828-38. PubMed ID: 26044363
[TBL] [Abstract][Full Text] [Related]
20. Multifucosylated Alpha-1-acid Glycoprotein as a Novel Marker for Hepatocellular Carcinoma.
Tanabe K; Kitagawa K; Kojima N; Iijima S
J Proteome Res; 2016 Sep; 15(9):2935-44. PubMed ID: 27354006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
